Kymera Therapeutics, Inc. (KYMR)
85.05
-2.30
(-2.63%)
USD |
NASDAQ |
Apr 10, 16:00
85.61
+0.56
(+0.66%)
After-Hours: 07:31
Kymera Therapeutics Accounts Payable (Quarterly) : 4.015M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 715.00M |
| Revolution Medicines, Inc. | 64.62M |
| Regeneron Pharmaceuticals, Inc. | 939.00M |
| Structure Therapeutics, Inc. | 13.86M |
| ACADIA Pharmaceuticals, Inc. | 10.90M |